Neil Fleshner
Chief Tech/Sci/R&D Officer bei POINT Biopharma, Inc. (United States)
Profil
Neil E.
Fleshner was the founder of POINT Biopharma Global, Inc. (founded in 2020) where he held the title of Director & Chief Medical Officer from 2021 to 2023.
He is currently the Director & Chief Medical Officer at POINT Biopharma Corp., Verity Pharmaceuticals, Inc., POINT Biopharma, Inc. (United States), and the University of Toronto.
In his former positions, he was the Director at Synergex Corp.
from 2005 to 2012, Director at the Canadian Urologic Oncology Group, Head-Urology Division at the University Health Network, and Head-Genitourinary Cancer Site Group at Princess Margaret Hospital.
Dr. Fleshner obtained a graduate degree from The Trustees of Columbia University in The City of New York in 1997 and a doctorate degree from the University of Toronto in 1988.
Aktive Positionen von Neil Fleshner
Unternehmen | Position | Beginn |
---|---|---|
University of Toronto | Corporate Officer/Principal | - |
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The private company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Chief Tech/Sci/R&D Officer | - |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Chief Tech/Sci/R&D Officer | 01.01.2020 |
Verity Pharmaceuticals, Inc.
Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | Chief Tech/Sci/R&D Officer | 01.07.2016 |
Ehemalige bekannte Positionen von Neil Fleshner
Unternehmen | Position | Ende |
---|---|---|
POIT BIOP | Founder | 27.12.2023 |
Canadian Urologic Oncology Group
Canadian Urologic Oncology Group BiotechnologyHealth Technology Canadian Urologic Oncology Group operates as a clinical research investigator network. The company is headquartered in Vancouver, Canada. | Director/Board Member | - |
University Health Network
University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Princess Margaret Hospital | Corporate Officer/Principal | - |
Synergex Corp.
Synergex Corp. Air Freight/CouriersTransportation Synergex Corp. provides supply chain management services in Latin America. It specializes in logistics services, distribution, licensing, sales, localization, packaging and marketing of digital entertainment products. The company was founded in 1986 and is headquartered in Mississauga, Canada. | Director/Board Member | - |
Ausbildung von Neil Fleshner
The Trustees of Columbia University in The City of New York | Graduate Degree |
University of Toronto | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
POIT BIOP | Health Technology |
Private Unternehmen | 7 |
---|---|
University Health Network
University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Health Services |
Synergex Corp.
Synergex Corp. Air Freight/CouriersTransportation Synergex Corp. provides supply chain management services in Latin America. It specializes in logistics services, distribution, licensing, sales, localization, packaging and marketing of digital entertainment products. The company was founded in 1986 and is headquartered in Mississauga, Canada. | Transportation |
Canadian Urologic Oncology Group
Canadian Urologic Oncology Group BiotechnologyHealth Technology Canadian Urologic Oncology Group operates as a clinical research investigator network. The company is headquartered in Vancouver, Canada. | Health Technology |
Princess Margaret Hospital | |
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The private company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Commercial Services |
Verity Pharmaceuticals, Inc.
Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | Health Technology |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |